CN103502244B - 一组提高激酶活性的化合物及其应用 - Google Patents
一组提高激酶活性的化合物及其应用 Download PDFInfo
- Publication number
- CN103502244B CN103502244B CN201180053876.7A CN201180053876A CN103502244B CN 103502244 B CN103502244 B CN 103502244B CN 201180053876 A CN201180053876 A CN 201180053876A CN 103502244 B CN103502244 B CN 103502244B
- Authority
- CN
- China
- Prior art keywords
- methyl
- anilino
- phenoxy group
- compound
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *C1COCC1 Chemical compound *C1COCC1 0.000 description 1
- IMRWILPUOVGIMU-UHFFFAOYSA-N Brc1ncccc1 Chemical compound Brc1ncccc1 IMRWILPUOVGIMU-UHFFFAOYSA-N 0.000 description 1
- DVUKAROOLHKKBC-UHFFFAOYSA-N CC(C)(C)C1CCOCC1 Chemical compound CC(C)(C)C1CCOCC1 DVUKAROOLHKKBC-UHFFFAOYSA-N 0.000 description 1
- AOKRXIIIYJGNNU-UHFFFAOYSA-N CC(CC1)CC1=O Chemical compound CC(CC1)CC1=O AOKRXIIIYJGNNU-UHFFFAOYSA-N 0.000 description 1
- YPWKAZSHYHFTIW-UHFFFAOYSA-N CC(CCC1)N1C(C)=O Chemical compound CC(CCC1)N1C(C)=O YPWKAZSHYHFTIW-UHFFFAOYSA-N 0.000 description 1
- ZRPDRTVUKWZQPO-UHFFFAOYSA-N CN(C)C(c(cc1)ncc1O)=O Chemical compound CN(C)C(c(cc1)ncc1O)=O ZRPDRTVUKWZQPO-UHFFFAOYSA-N 0.000 description 1
- XNZNBGDEQXOMQZ-UHFFFAOYSA-N CN(C)C(c(cc1)ncc1OCC(C=C1)(C=C1Nc1ccccn1)N(CCC1)C1=O)=O Chemical compound CN(C)C(c(cc1)ncc1OCC(C=C1)(C=C1Nc1ccccn1)N(CCC1)C1=O)=O XNZNBGDEQXOMQZ-UHFFFAOYSA-N 0.000 description 1
- XCVISTUVICVYSW-UHFFFAOYSA-N CN(C)C(c(cc1)ncc1Oc(c(C=O)c1)ccc1[N+]([O-])=O)=O Chemical compound CN(C)C(c(cc1)ncc1Oc(c(C=O)c1)ccc1[N+]([O-])=O)=O XCVISTUVICVYSW-UHFFFAOYSA-N 0.000 description 1
- BSJSDZPZBHUYIF-UHFFFAOYSA-N CN(C)C(c(cc1)ncc1Oc(c(CN(CCC1)C1=O)c1)ccc1[NH+](C)[O-])=O Chemical compound CN(C)C(c(cc1)ncc1Oc(c(CN(CCC1)C1=O)c1)ccc1[NH+](C)[O-])=O BSJSDZPZBHUYIF-UHFFFAOYSA-N 0.000 description 1
- WGQRTPNCLFYJFL-UHFFFAOYSA-N CN(C)C(c(cc1)ncc1Oc(c(CO)c1)ccc1N=O)=O Chemical compound CN(C)C(c(cc1)ncc1Oc(c(CO)c1)ccc1N=O)=O WGQRTPNCLFYJFL-UHFFFAOYSA-N 0.000 description 1
- ODBUMEFPKKDUAC-UHFFFAOYSA-N CN(C)C(c(cc1)ncc1Oc(c(COS(C)(=O)=O)c1)ccc1[N+]([O-])=O)=O Chemical compound CN(C)C(c(cc1)ncc1Oc(c(COS(C)(=O)=O)c1)ccc1[N+]([O-])=O)=O ODBUMEFPKKDUAC-UHFFFAOYSA-N 0.000 description 1
- PQUSAOKJJUXOTR-UHFFFAOYSA-N CN(C)C(c(cc1)ncc1Oc(cc1)c(CN(CCC2)C2=O)cc1N)=O Chemical compound CN(C)C(c(cc1)ncc1Oc(cc1)c(CN(CCC2)C2=O)cc1N)=O PQUSAOKJJUXOTR-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N CN(CCC1)C1=O Chemical compound CN(CCC1)C1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- DSADIJSJMSGEAK-UHFFFAOYSA-N Cc(c(C=O)c1)ccc1N=O Chemical compound Cc(c(C=O)c1)ccc1N=O DSADIJSJMSGEAK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/803—Processes of preparation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
Description
实施例 | EC50,葡糖激酶活性(μM) |
实施例6 | 2 |
实施例13 | 2 |
实施例65 | 5 |
实施例78 | 1.5 |
Claims (39)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410464622.XA CN104230892B (zh) | 2011-11-09 | 2011-11-09 | 一组提高激酶活性的化合物及其应用 |
CN201180053876.7A CN103502244B (zh) | 2010-11-09 | 2011-11-09 | 一组提高激酶活性的化合物及其应用 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010535640.4 | 2010-11-09 | ||
CN201010535640 | 2010-11-09 | ||
PCT/CN2011/082004 WO2012062210A1 (en) | 2010-11-09 | 2011-11-09 | Compound for increasing kinase active and application thereof |
CN201180053876.7A CN103502244B (zh) | 2010-11-09 | 2011-11-09 | 一组提高激酶活性的化合物及其应用 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410464622.XA Division CN104230892B (zh) | 2011-11-09 | 2011-11-09 | 一组提高激酶活性的化合物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103502244A CN103502244A (zh) | 2014-01-08 |
CN103502244B true CN103502244B (zh) | 2014-10-08 |
Family
ID=46050413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180053876.7A Active CN103502244B (zh) | 2010-11-09 | 2011-11-09 | 一组提高激酶活性的化合物及其应用 |
Country Status (8)
Country | Link |
---|---|
US (1) | US9409900B2 (zh) |
EP (1) | EP2638036B1 (zh) |
JP (1) | JP6038037B2 (zh) |
KR (2) | KR101643721B1 (zh) |
CN (1) | CN103502244B (zh) |
AU (1) | AU2011328673B2 (zh) |
SG (2) | SG10201509157QA (zh) |
WO (1) | WO2012062210A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202330916A (zh) | 2021-09-17 | 2023-08-01 | 美商旗艦先鋒創新有限責任公司 | 用於產生環狀多核糖核苷酸之組成物和方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001074771A1 (en) * | 2000-04-04 | 2001-10-11 | Smithkline Beecham P.L.C. | Pyrrole-2,5-dione derivatives for the treatment of diabetes |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3632042A1 (de) | 1986-03-08 | 1987-09-10 | Bayer Ag | Diarylsulfidderivate |
JPS62212378A (ja) * | 1986-03-08 | 1987-09-18 | バイエル・アクチエンゲゼルシヤフト | ジアリ−ルスルフイド誘導体 |
US6719520B2 (en) * | 1998-10-08 | 2004-04-13 | Smithkline Beecham Corporation | Method and compounds |
EP1119548B1 (en) * | 1998-10-08 | 2004-12-08 | SmithKline Beecham plc | 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrole-2,5-dione as glycogen synthase kinase-3 inhibitor (gsk-3) |
UA71945C2 (en) * | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
EP1127882A1 (en) * | 2000-01-25 | 2001-08-29 | Pfizer Products Inc. | Tetrazole compounds as thyroid receptor ligands |
JP3598994B2 (ja) * | 2000-07-10 | 2004-12-08 | セイコーエプソン株式会社 | 電気光学装置の製造方法 |
DE60212487T2 (de) * | 2001-04-13 | 2006-12-21 | Pfizer Products Inc., Groton | Bizyklisch substituierte 4-Aminopyridopyrimidinderivate |
WO2003026664A1 (en) | 2001-09-26 | 2003-04-03 | Bayer Corporation | 2-phenylamino-4- (5-pyrazolylamino) -pyramidine derivatives as kinase inhibitors, in particular, src kinase inhibitors |
DE10153396A1 (de) * | 2001-11-01 | 2003-05-28 | Siemens Ag | Einrichtung zur Ansteuerung einer elektrischen Kraftstoffpumpe |
CA2530538A1 (en) * | 2003-07-09 | 2005-01-20 | Keith Roger Bley | Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
JP5036316B2 (ja) * | 2004-11-02 | 2012-09-26 | Msd株式会社 | アリールオキシ置換ベンズイミダゾール誘導体 |
JP2010540460A (ja) * | 2007-09-24 | 2010-12-24 | トラガラ ファーマシューティカルズ,インク. | COX‐2阻害薬と抗HER2[ErbB2]抗体の混合物又はCOX‐2阻害薬とHER2[ErbB2]受容体チロシンキナーゼ阻害薬の混合物を用いた癌の治療 |
ES2635504T3 (es) * | 2009-01-21 | 2017-10-04 | Rigel Pharmaceuticals, Inc. | Derivados de N2-(3-piridilo o fenil)-N4-(4-piperidil)-2,4-pirimidinadiamina útiles en el tratamiento de enfermedades inflamatorias, toimmunitarias o proliferativas |
-
2011
- 2011-11-09 CN CN201180053876.7A patent/CN103502244B/zh active Active
- 2011-11-09 WO PCT/CN2011/082004 patent/WO2012062210A1/en active Application Filing
- 2011-11-09 US US13/884,470 patent/US9409900B2/en active Active
- 2011-11-09 AU AU2011328673A patent/AU2011328673B2/en not_active Ceased
- 2011-11-09 KR KR1020157025687A patent/KR101643721B1/ko active IP Right Grant
- 2011-11-09 KR KR1020137014756A patent/KR20140016245A/ko active Application Filing
- 2011-11-09 JP JP2013538052A patent/JP6038037B2/ja active Active
- 2011-11-09 SG SG10201509157QA patent/SG10201509157QA/en unknown
- 2011-11-09 SG SG2013036041A patent/SG190784A1/en unknown
- 2011-11-09 EP EP11839459.2A patent/EP2638036B1/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001074771A1 (en) * | 2000-04-04 | 2001-10-11 | Smithkline Beecham P.L.C. | Pyrrole-2,5-dione derivatives for the treatment of diabetes |
Also Published As
Publication number | Publication date |
---|---|
US9409900B2 (en) | 2016-08-09 |
KR20140016245A (ko) | 2014-02-07 |
EP2638036A4 (en) | 2014-09-03 |
EP2638036B1 (en) | 2017-08-16 |
WO2012062210A1 (en) | 2012-05-18 |
CN103502244A (zh) | 2014-01-08 |
KR101643721B1 (ko) | 2016-07-28 |
US20130225587A1 (en) | 2013-08-29 |
JP6038037B2 (ja) | 2016-12-07 |
AU2011328673A8 (en) | 2013-07-25 |
AU2011328673B2 (en) | 2016-02-25 |
SG10201509157QA (en) | 2015-12-30 |
AU2011328673A1 (en) | 2013-07-04 |
SG190784A1 (en) | 2013-07-31 |
JP2014500252A (ja) | 2014-01-09 |
EP2638036A1 (en) | 2013-09-18 |
KR20150109501A (ko) | 2015-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112424174B (zh) | 可用于治疗疾病的杂环化合物 | |
CA2998741C (en) | Hepatitis b core protein modulators | |
CN102036981B (zh) | 取代的4-羟基嘧啶-5-甲酰胺 | |
EP1442024B1 (en) | AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS | |
CN101213183A (zh) | 氨基-5-(6元)杂芳基咪唑酮化合物和在β-分泌酶调节中的用途 | |
TWI617308B (zh) | 犬尿胺酸-3-單氧化酶抑制劑、其醫藥組成物及其使用方法 | |
CA2927560A1 (en) | Hepatitis b viral assembly effectors | |
CN101360737A (zh) | 2-氨基-5-哌啶咪唑酮化合物和其用于β分泌酶调节的用途 | |
JP2006518381A (ja) | プロテインキナーゼのインヒビターとして有用なヘテロアリール置換ピロール | |
CA2463822A1 (en) | Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) | |
CN103145702A (zh) | 用作激酶抑制剂的氨基嘧啶 | |
JP6896701B2 (ja) | イミダゾリルアミド誘導体 | |
AU2002363176A1 (en) | Heteroaryl amines as glycogen synthase kinase 3Beta inhibitors (GSK3 inhibitors) | |
JP2010138073A (ja) | ピコリン酸アミド化合物 | |
CN102015715A (zh) | 作为trpv3调节剂的稠合嘧啶酮 | |
WO2012089106A1 (zh) | 作为蛋白激酶抑制剂的芳炔类衍生物及其医疗用途 | |
KR20110002465A (ko) | 세포 보호 작용을 갖는 피리미딘 유도체 및 그 용도 | |
WO2016160938A1 (en) | N-(1,3-thiazol-2-yl)pyrimidine-5-carboxamides as trpv3 modulators | |
CN103502244B (zh) | 一组提高激酶活性的化合物及其应用 | |
CN102482267B (zh) | 作为葡萄糖激酶(gk)活化剂的取代苯甲酰胺衍生物 | |
CN104230892A (zh) | 一组提高激酶活性的化合物及其应用 | |
TWI475016B (zh) | 一組提高激酶活性的化合物及其應用 | |
EP3401310B1 (en) | Phenylimidazole compound | |
CA2784153C (fr) | Nouveaux derives (heterocycle-tetrahydro-pyridine)-(piperazinyl)-1-alcanone et (heterocycle-dihydro-pyrrolidine)-(piperazinyl)-1-alcanone et leur utilisation comme inhibiteurs de p75 | |
JP2024517504A (ja) | アゼチジン環状尿素を含めたrip1調節物質、その調製、及び使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 350008 No. 20, Jinzhou North Road, Jinshan Industrial Park, Cangshan District, Fuzhou City, Fujian Province Patentee after: FUJIAN HAIXI PHARMACEUTICALS Co.,Ltd. Patentee after: BETTA PHARMACEUTICALS Co.,Ltd. Patentee after: Kang Xinshan Address before: 350008 No. 20, Jinzhou North Road, Jinshan Industrial Park, Cangshan District, Fuzhou City, Fujian Province Patentee before: FUJIAN HAIXI PHARMACEUTICALS Co.,Ltd. Patentee before: ZHEJIANG BETA PHARMA Inc. Patentee before: Kang Xinshan |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220112 Address after: 350008 No. 20, Jinzhou North Road, Jinshan Industrial Park, Cangshan District, Fuzhou City, Fujian Province Patentee after: FUJIAN HAIXI PHARMACEUTICALS Co.,Ltd. Patentee after: BETTA PHARMACEUTICALS Co.,Ltd. Address before: 350008 No. 20, Jinzhou North Road, Jinshan Industrial Park, Cangshan District, Fuzhou City, Fujian Province Patentee before: FUJIAN HAIXI PHARMACEUTICALS Co.,Ltd. Patentee before: BETTA PHARMACEUTICALS Co.,Ltd. Patentee before: Kang Xinshan |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: The third and fourth floors of Block B, No. 177 Jinda Road, Jianxin Town, Cangshan District, Fuzhou City, Fujian Province, 350000 Patentee after: Fujian Haixi New Pharmaceutical Co.,Ltd. Patentee after: BETTA PHARMACEUTICALS Co.,Ltd. Address before: 350008 No. 20, Jinzhou North Road, Jinshan Industrial Park, Cangshan District, Fuzhou City, Fujian Province Patentee before: FUJIAN HAIXI PHARMACEUTICALS Co.,Ltd. Patentee before: BETTA PHARMACEUTICALS Co.,Ltd. |